Chulalongkorn Hospital
Bangkok, 10330, Thailand
NCT Number: NCT05808556
The aims of the study were to evaluate efficacy and safety of the sticker pads containing lavender and ylang ylang oil in high blood pressure volunteers
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bangkok, 10330, Thailand
High blood pressure volunteers were divided into the sticker group or the placebo group. The volunteers attached the pad to their shirt for 3, 7, 10, and 14 days. Blood pressure, pulse rate, adverse reactions, and satisfaction were investigated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The sticker pad group attached an sticker pad (0.3% lavender oil and 0.7% ylang ylang oil) to their shirt, close to the right side of the neck, for 14 days,
The placebo group attached a sticker pad without lavender and ylang ylang oil to their shirt, close to the right side of the neck, for 14 days.
Time frame: 14 days
Measure systolic blood pressure in mmHg
Time frame: 14 days
Measure diastolic blood pressure in mmHg
Time frame: 14 days
Measure pulse rate in beats/minutes
Time frame: 14 days
Using a score of 0 to 3, following an increase of severity
Time frame: 14 days
Using a visual analogue scale, 0 means not satisfied, 10 means very satisfied
Chulalongkorn University
Other
Efficacy and Safety of Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07648758
Cardiovascular Diseases, High Blood Pressure
Dallas, Texas, United States
View Trial DetailsNCT06508619
Cardiovascular Diseases, High Blood Pressure
Delft, South Holland, Netherlands
View Trial DetailsNCT04255745
Atrophy, Behavior
Chicago, Illinois, United States
View Trial DetailsNCT04114669
Cardiovascular Diseases, High Blood Pressure
New York, United States
View Trial Details